Articles tagged with Misfolded Proteins
A Penn study reveals how cells remove misfolded proteins, a crucial process for understanding brain diseases caused by toxic protein clumps. The research identified a two-stage recycling system involving proteins PML and RNF4 that tags misfolded proteins for degradation.
Researchers found exercise training significantly reduces HSP90 overexpression in PD rats, suggesting a potential therapeutic target for skeletal muscle abnormalities. This study supports the use of HSP90 inhibitors as a new treatment option for PD-related muscle issues.
Researchers have engineered a series of molecules with the potential to treat most neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's. The GAIM-changing molecules recognize characteristic common to many toxic misfolded proteins and can prevent new aggregates from forming while clearing existing ones.
Researchers at Rice University have designed a sophisticated synthetic genetic circuit that signals increases in the degradation of proteins by the cell's ubiquitin proteasome system (UPS). The Deg-On circuit produces a green fluorescent signal linked to UPS degradation, allowing researchers to monitor proteasomal activity.
Researchers have developed a new technology to detect misfolded protein fragments, known as Aβ oligomers, in cerebrospinal fluid that could lead to early diagnosis of Alzheimer's disease. The test showed high sensitivity and specificity, distinguishing between Alzheimer's patients and those with other neurodegenerative disorders.
Scientists at Scripps Research Institute develop new probes to detect functional, normally folded, and disease-associated misfolded conformations of proteins in cells. The technology paves the way for discovering new drugs for misfolding diseases such as Alzheimer's and Parkinson's.
Aging disrupts sleep patterns in fruit flies, leading to increased protein misfolding and cellular stress. A molecular chaperone treatment restored youthful sleep patterns, suggesting a potential therapeutic approach to addressing age-related sleep disorders.
Huntington's disease is caused by an expansion in the polyglutamine tract of a protein called Huntingtin, leading to its misfolding and aggregation. Researchers have discovered that transient intermediate species called oligomers play a key role in neurotoxicity, rather than fibrillar aggregates. Modulating these oligomers through mole...
A study led by University of British Columbia researchers reveals how the fatal neurodegenerative disease ALS is transmitted from cell to cell. The research shows that misfolded non-mutant SOD1 can be transmitted regionally in the nervous system, offering a molecular explanation for ALS progression.
Researchers at the University of Southampton have discovered a key role for astrocytes and specific proteins in supporting neurons during protein misfolding brain diseases. The study found that certain proteins increase in response to misfolded proteins, potentially providing protection against neuronal death.
Researchers have discovered a way to unravel misfolded proteins using 'reprogrammed' Hsp104, a common yeast protein. The study found that minor mutations in the middle domain of Hsp104 can unlock its clump-busting capabilities, offering a potential therapeutic opportunity for brain diseases such as ALS and Alzheimer's.
A team of researchers has pinpointed a critical intermediate step in the chemical pathway that leads to amyloid fibril formation, which is implicated in type 2 diabetes and other diseases. The findings provide a new target for potential treatment, such as designing an inhibitor drug to block the harmful pathway.
Researchers at OHSU discovered a way to use small molecules to fix misfolded proteins, allowing them to function normally again. This technique has the potential to treat diseases such as cystic fibrosis, cataracts, and Alzheimer's disease.
Rice University researchers used computer models to study the behavior of misfolded proteins, finding that they can form branching structures similar to those found in spider silk. These structures may be an early stage in the formation of amyloid plaques associated with Alzheimer's disease.
Scientists found that BMAA inserts itself into neuroproteins by seizing transfer RNA, causing misfolding and aggregation. Adding extra L-Serine can prevent this process, offering a potential prevention method for ALS.
Researchers Charles Weissmann and Adriano Aguzzi received the prestigious Hartwig Piepenbrock-DZNE Prize for their groundbreaking work on prion diseases. Their findings shed light on fundamental mechanisms of neurodegenerative disorders, including Alzheimer's and Parkinson's disease.
Researchers found two distinct strains of alpha-synuclein that promote different patterns of misfolding, leading to unique sets of symptoms in neurodegenerative disorders. The study suggests that different structural shapes of the protein may contribute to co-occurrence of synuclein and tau accumulations in certain brain diseases.
Researchers have discovered that a single protein, alpha-synuclein, can exist in two different structural shapes, or 'strains', which promote misfolding of other disease proteins commonly found in Alzheimer's and Parkinson's. This finding has significant implications for the development of therapies for neurodegenerative diseases.
Researchers at UB's Hunter James Kelly Research Institute have found that reducing a protein called Gadd34 can improve nerve and muscle function in patients with CMT neuropathies. By leaving protein synthesis partially off, they were able to restore myelination, potentially leading to new treatments for other misfolded protein diseases.
Scientists have successfully observed protein unfolding at atomic resolution, revealing the intermediate forms that occur during folding. The study may contribute to a better understanding of how proteins misfold in diseases like Alzheimer's, Parkinson's, and Huntington's Chorea.
Researchers at UNC School of Medicine found striking similarities between heart cells and brain cells in patients with Alzheimer's disease, suggesting a new treatment paradigm for heart failure. Misfolded proteins in heart cells are a key factor in the process of heart failure.
Researchers at Rice University used the AWSEM-MD software to simulate protein folding and found a surprising twist: short sequences can self-recognize and stick together, leading to misfolding. This discovery provides new insights into degenerative diseases and may lead to drug design.
Researchers at Rice University have discovered a new way to monitor protein aggregation in living cells, which could lead to the development of drugs that break up fibrils. The metallic probe, made of ruthenium, binds with misfolded alpha-synuclein proteins and can be tracked using photoluminescence spectroscopy.
Researchers have identified 21 proteins that interact with ataxin-1, which can enhance or prevent its misfolding and toxicity. The study found that proteins with a specific structure called 'coiled-coil-domain' promote aggregation and toxic effects.
Researchers at the University of California, San Diego have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause neurodegeneration in Huntington's disease. PGC-1alpha and TFEB provide a new therapeutic target for treating the disease, offering hope for its treatment.
Researchers discovered that master regulator protein ATF6α brings a plethora of coactivators to gene expression sites, activating downstream genes involved in the ER stress response. The study suggests ways to dampen ER stress signaling molecularly and could reveal new targets for diseases like Alzheimer's and Huntington's Diseases.
Researchers have identified a process by which misfolded proteins, such as alpha-synuclein, travel from sick to healthy cells in the brain, leading to the progression of Parkinson's disease. The study provides new insights into the disease's pathology and offers potential targets for disease-modifying treatments.
Researchers at UTSC used electroanalytic technique voltammetry to study dopamine and alpha-synuclein interactions, finding that higher pH levels and ionic strengths facilitate aggregate formation. The findings could lead to new ways to screen drugs for Parkinson's disease treatment.
Researchers found that alpha-synuclein fibrils can induce normal a-syn to misfold, leading to neurodegeneration. The study suggests that the corrupted form of a-syn can be transmitted from diseased neurons to healthy ones via white-matter tracks.
Researchers developed a computer program to track dementia spread in the human brain, predicting future cognitive declines. The model identifies neural sub-networks where misfolded proteins collect, altering normal brain function across affected areas.
The Helmholtz Association is funding a research project to develop a standardized screening platform for identifying active agents to treat protein misfolding diseases such as Alzheimer's and Parkinson's. The grant will be matched by the MDC, allowing researchers to test larger libraries of potential active agents.
Researchers have developed an algorithm to predict how and when proteins misfold, leading to neurodegenerative diseases. The algorithm helps scientists understand protein dynamics and may aid in developing treatments for currently incurable diseases.
Scientists at Scripps Research Institute have identified a single prion protein that causes neuronal death similar to 'mad cow' disease, with toxic effects up to 10 times more potent than larger prion species. The study opens new avenues for exploring neurodegenerative disorders like Alzheimer's and Parkinson's diseases.
A team of chemists at the University of Pennsylvania has developed a method to watch proteins fold in real-time, allowing for a better understanding of protein folding and misfolding. This technique uses infrared spectroscopy to analyze structural changes as a function of time, providing insights into protein folding mechanisms.
Researchers at Gladstone Institutes discovered a protein form linked to Huntington's disease that influences symptom timing and severity. The study offers new avenues for treating not only Huntington's but also similar conditions like Alzheimer's and type 1 diabetes.
Researchers found that a genetic switch in master neurons inhibits the proper functioning of protective cell stress responses, accumulating misfolded and damaged proteins. Restoring this natural ability could offer a new target for therapy, improving cellular health and quality of life.
Scientists have discovered a common cause of all forms of ALS, a fatal neurodegenerative disease, by identifying a broken down protein recycling system in neurons. This finding provides a common target for drug therapy and suggests that all types of ALS are tributaries pouring into a common river of cellular incompetence.
Researchers at UNC School of Medicine have devised a gene therapy cocktail that can treat some inherited diseases caused by misfolded proteins. The approach uses an adeno-associated virus (AAV) vector to deliver two payloads simultaneously: one disables the mutant protein and another provides a new gene to replace its activity.
Researchers found that MAVS proteins, similar to deadly prions, play a crucial role in innate immunity by forming clusters on mitochondrial membranes to defend against viral assault. This discovery may deepen our knowledge of host defense and provide insights into the development of new treatments for prion-related diseases.
Research in yeast reveals that cellular stress can induce the formation of infectious protein particles called prions, which are associated with neurodegenerative disorders. The study identifies a protein called Lsb2 that promotes spontaneous prion formation under stress conditions.
Researchers at North Carolina State University have figured out how copper induces misfolding in the protein associated with Parkinson's disease. This finding has implications for both the study of Parkinson's progression and future treatments. The researchers used computer simulations to ferret out the most likely binding scenario, re...
Studies using single-molecule fluorescence reveal that neighboring protein domains with similar amino acid sequences are more prone to misfold, potentially leading to neurodegenerative diseases. This finding suggests that proteins have evolved to limit similarity between domains to prevent misfolding and maintain functionality.
Researchers at Brown University have discovered that mutant prions can aid cells in overcoming harmful protein misfolding, a process thought to be catastrophic. The findings suggest that targeted interventions at various stages of the misfolding process can enable cells to overcome the problem.
Researcher Ron Kopito shows that mutant misfolded protein responsible for Huntington's disease can move from cell to cell, recruiting normal proteins and forming aggregations in each cell it visits. This ability could explain the progression of neurodegenerative diseases like Parkinson's and Alzheimer's through the brain.
Researchers at the University of Leeds have uncovered the first misfold that triggers the formation of amyloid fibres, a critical step in understanding these disease-causing structures. This discovery offers new targets for therapies and may shed light on other protein-related diseases.
A team of researchers at Brown University found that the size of prion protein aggregates, not their number, determines their efficiency in spreading in yeast cells. The study suggests that controlling aggregate size may be a more effective strategy for developing treatments for prion infection and potentially other neurodegenerative d...
Researchers at UC San Diego identified misfolding of neuroligin-3 due to gene mutations, leading to trafficking deficiencies and abnormal neuron communications. The findings advance understanding of autism causes and may offer new drug therapies.
Researchers have discovered a small molecule, IU1, that helps human cells get rid of misfolded proteins implicated in Alzheimer's disease and other neurodegenerative ailments. This potential drug could have applications for other conditions as well.
Researchers discovered a specific mutation that promotes fibril development, leading to organ damage and death. The study suggests this finding could be a target for future drug development in treating the fatal condition.
Scientists at TUM developed a novel method to observe local movements in proteins on a time scale of nanoseconds to microseconds. They found two structures of the villin protein that were previously undistinguishable from one another, with different dynamic properties.
Researchers at Yale School of Medicine have developed a simple urine test to rapidly predict and diagnose preeclampsia in pregnant women. The Congo Red Dot Test accurately predicted preeclampsia in a study of 347 pregnant women, allowing for better preventive care.
Researchers discovered protein misfolding coincides with loss of heat shock response in C. elegans, suggesting protective mechanism deficient during aging. Early intervention with a 'vitamin' equivalent boosts heat shock response, delaying protein misfolding and extending lifespan.
Scripps Research scientists discover a new drug tafamidis that significantly halts disease progression for patients with Transthyretin amyloid polyneuropathy. The drug targets protein misfolding, providing a potential therapeutic strategy for this rare inherited disease.
Whitehead Institute researchers have identified 24 prion candidates in yeast, shifting the view from biological anomalies to mediators of trait inheritance. Prions in yeast appear to prepare individual organisms for environmental changes, sometimes providing a survival advantage.
Researchers at Yale University have identified misfolded proteins in the urine of pregnant women as a potential cause of preeclampsia. The discovery, made using proteomics and a novel dye test, offers a new approach to early diagnosis and treatment of the disease.
Researchers discovered that misfolded proteins trigger a mechanism in yeast cells, allowing them to adapt to stress and evolve more quickly. Under stressful conditions, the cells create prions, which can induce beneficial changes, such as enhanced growth on energy sources or resistance to antibiotics.
Scientists have discovered a new clue for understanding how misfolded proteins cause cell death in Huntington's disease. The study found that polyQ-expanded proteins interact with and trap other proteins, leading to a breakdown in protein quality control, which may contribute to the disease's toxicity.
Researchers have successfully created new strains of infectious proteins called prions by mixing infectious prions from one species with normal prion proteins from another. This breakthrough could provide insight into the risk of prion diseases spreading between species and has significant implications for public health.
A team of researchers has discovered the key component of a human cell's quality control mechanism, known as ERdj5, which plays a crucial role in degrading misfolded proteins. This breakthrough has significant implications for developing new treatments for cystic fibrosis and other hereditary diseases.
Fernandez-Funez will study ways to protect brain cells from damage by prions using genetically engineered flies that produce proteins like those found in 'mad cow' disease. His goal is to find new mechanisms of prion neurotoxicity and develop protective chaperone proteins.